Hard to Treat Diseases (HTDS)
BELGRADE, Serbia, January 7 - Hard to Treat Diseases (HTDS.PK) (www.htdsmedical.com)
Slavica Bio Chem operating subsidiary (www.slavicabiochem.com ) is
proud to report that IBISS research group is invited, as a representative of
Serbia, to participate in the 13th Moscow International Salon of Inventions
and Innovation Technologies "Archimedes" that is to be held from March 30 to
April 2, 2010 in Moscow, Russia.
SHENZHEN, China, November 18 - Hard to Treat Diseases (HTDS; www.htdsmedical.com) and its China
subsidiary Mellow Hope announce that they have acquired a Registration
Certificate for Mellow Hope's H1N1 Influenza A Vaccine from the government
of Chile and the first vaccines will ship in a matter of weeks.
SHENZHEN, China, November 17 - Hard to Treat Diseases (HTDS; www.htdsmedical.com) and its China
subsidiary Mellow Hope announce that its MMR vaccine (Measles, Mumps and
Rubella Combined Vaccine Live) had obtained a "pass" on its First Drug
Evaluation.
SHENZHEN, China - Hard To Treat Diseases (OTC: HTDS) www.htdsmedical.com, announced today that Novartis, a US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 million.
